Gain Therapeutics, Inc.GANXNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-0.6%
5Y CAGR+38.0%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-0.6%/yr
vs +103.3%/yr prior
5Y CAGR
+38.0%/yr
Recent deceleration
Acceleration
-103.9pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
5x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$17.58M-13.6%
2024$20.35M-8.8%
2023$22.31M+24.6%
2022$17.91M+28.3%
2021$13.96M+297.9%
2020$3.51M+63.8%
2019$2.14M+104.2%
2018$1.05M-